A Multicentre, Double-Blind, Placebo-Controlled, Adaptive Pivotal Study of the Efficacy and Safety of Oral BC1036 in the Management of Cough
The purpose of this study is to investigate the effect of BC1036 (theobromine) on cough-related quality of life and cough severity following 2 weeks' treatment.
A Multicentre, Double-Blind, Placebo-Controlled, Adaptive Pivotal Study of the Efficacy and Safety of Oral BC1036 in the Management of Cough
100 项与 Respicopea, Inc. 相关的临床结果
0 项与 Respicopea, Inc. 相关的专利（医药）
100 项与 Respicopea, Inc. 相关的药物交易
100 项与 Respicopea, Inc. 相关的转化医学
